Trial intelligence / Profile preview

CIRCE: Induction Gemcitabine and Cisplatin in Advanced Cervical Cancer

NCT01973101Phase 2Unknown

Sponsor
Instituto do Câncer do Estado de São Paulo
Start
Jun 2012
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gemcitabine in Cervical Cancer (CC), sponsored by Instituto do Câncer do Estado de São Paulo. Status: unknown.

02

Drugs

gemcitabine
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT01973101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01973101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call